Has Derek Delmonte, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,956 in general payments to Derek Delmonte, MD across 136 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Derek Delmonte, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Derek Delmonte, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Derek Delmonte, MD

Ophthalmology · Greensboro, NCNPI 1528225471

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $18,850 of the $26,956 with a category attached, or 69.9%. Glaukos Corporation accounts for 73.2% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $13,642, 6.7 times the $2,034 reported in 2019. Among ophthalmology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,956in general payments, 2019–2025

Across 136 payments — averaging $198.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Glaukos Corporation$20K
Johnson & Johnson Surgical Vision, Inc.$4K
Alcon$1K
AbbVie$323
Rxsight Inc$315
Bausch & Lomb Americas Inc.$197
plus $1K from 15 others

What the payments were for

Consulting fees$18,85070%
Travel & lodging$3,45013%
Food & beverage$4,65717%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Glaukos Corporation	46	$19,725
Johnson & Johnson Surgical Vision, Inc.	11	$3,891
Alcon	33	$1,301
AbbVie(2 entities)	12	$323
Rxsight Inc	1	$315
Bausch & Lomb Americas Inc.	6	$197
NEW World Medical,inc.	3	$151
Astellas Pharma US Inc	2	$148
Regeneron Healthcare Solutions, Inc.	2	$144
Microsurgical Technology, Inc.	1	$133
Amgen	5	$125
Nova Eye, Inc.	1	$100
Oyster Point Pharma, Inc.	1	$96
Eyepoint US, Inc.	3	$65
Novartis	1	$65
Harrow Eye, LLC	2	$55
ANI Pharmaceuticals, Inc.	2	$34
Tarsus Pharmaceuticals, Inc.	1	$31
Mallinckrodt Hospital Products Inc.	1	$29
Omeros Corporation	1	$17
Carl Zeiss Meditec Cataract Technology Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Epioxa$7,088
CE-marked KXLA system$5,500
KXL System$4,144
Travoprost Intraocular Implant - iDose$2,459
Catalys Laser System$2,125
Tecnis 1-piece IOL$2,125
Tecnis 3-piece IOL$2,125
Unfolder IOL Delivery Systems$2,125
Clareon$384
RXSIGHT CONTACT LENS$315
RXSIGHT INJECTOR CARTRIDGE$315
RXSIGHT INJECTOR HANDPIECE$315
RXSIGHT LIGHT DELIVERY DEVICE (LDD)$315
LIGHT ADJUSTABLE LENS (LAL)$315
AcrySof$145
ReSTOR$140
Photrexa$140
Clareon PanOptix Pro$125
EYLEA HD$122

How this compares

$26,956 in reported general payments places this provider in the 90th percentile of 588 ophthalmology providers in North Carolina.

See all ophthalmology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$101,566

Medicare patients

195

Services billed

504

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	340	$17,382
ValacyclovirValacyclovir Hcl	33	$2,529
MoxifloxacinMoxifloxacin Hcl	68	$1,885
ErythromycinErythromycin Base	21	$162

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Greensboro

Karl StonecipherGreensboro$653K
Paula PecenGreensboro$9K
Preeya GuptaRaleigh$1.8M
Julie WoodwardDurham$1M
Rajiv ShahWinston Salem$909K
Lejla VajzovicDurham$681K
Terry KimDurham$605K
Keith WalterWinston Salem$397K
Leon HerndonDurham$230K
Thomas MundorfCharlotte$220K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →